OLMA

Olema Pharmaceuticals, Inc. OLMA

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Pending next ranking run

This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Top Institutional Holders

as of Q2 2026
$1.27B total
FMR LLC
$151.91M+16.9%
Paradigm Biocapital Advisors LP
$108.47M+8.1%
Jupiter Topco LLC
$88.80M--
Bain Capital Life Sciences Investors, LLC
$88.64M-5.2%
BlackRock, Inc.
$84.00M+18.8%
BVF INC/IL
$66.25M0.0%
Siren, L.L.C.
$60.76M+2.1%
STATE STREET CORP
$53.99M+9.6%
VANGUARD CAPITAL MANAGEMENT LLC
$41.80M+8.4%
Logos Global Management LP
$40.14M0.0%
FRANKLIN RESOURCES INC
$29.39M+92.8%
Cormorant Asset Management, LP
$26.90M-44.9%
MORGAN STANLEY
$22.92M+50.7%
GEODE CAPITAL MANAGEMENT, LLC
$22.76M+17.8%
VANGUARD PORTFOLIO MANAGEMENT LLC
$20.81M+180.5%
GOLDMAN SACHS GROUP INC
$19.62M+50.0%
Deep Track Capital, LP
$18.77MNew
DIMENSIONAL FUND ADVISORS LP
$17.72M+30.9%
Lightspeed Management Company, L.L.C.
$16.95M0.0%
KINGDON CAPITAL MANAGEMENT, L.L.C.
$15.01M+40.4%
TWO SIGMA INVESTMENTS, LP
$14.15M-3.2%
Point72 Asset Management, L.P.
$13.40M+1406.1%
Duquesne Family Office LLC
$12.35M0.0%
Defilade Capital Management, L.P.
$11.57M-38.5%
AMERIPRISE FINANCIAL INC
$10.52M+1365.5%
See all 186 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

ROIC

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/OLMA

Earnings Per Share

13fpro.ai/company/OLMA

Loading ratio trend…

OLMA insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About Olema Pharmaceuticals, Inc. (OLMA): stock profile, AI score and financials

Olema Pharmaceuticals, Inc. (OLMA) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. OLMA is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Top institutional holders of OLMA by reported 13-F value include FMR, Paradigm Biocapital Advisors, Jupiter Topco, based on the most recent SEC filings. OLMA trades on the Nasdaq exchange and files with the SEC under CIK 1750284. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate OLMA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Olema Pharmaceuticals, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1750284 →